Xeris Biopharma Appoints Menassie M. Taddese to Board of Directors

• Xeris Biopharma appointed Menassie M. Taddese to its board, effective today. He will also serve on the Audit Committee.
• Taddese most recently served as president of emerging markets at Viatris. His background includes more than 20 years at Pfizer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261102898192) on November 02, 2026, and is solely responsible for the information contained therein.